About Frost & Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.awards.frost.com.
About Transport Pharmaceuticals, Inc.
Transport is bringing together cutting-edge medical electronics with
drug formulation and material sciences to develop drug/device combination
products that enhance movement of drugs across the stratum corneum (the
skin's outer layer) by means of electric current. Transport's lead product,
the SoloVir(TM) Electrokinetic Transdermal System (SoloVir(TM) ETS),
utilizes the company's proprietary five-percent acyclovir gel-formulation
to treat herpes labialis, or cold sores. Pharmacokinetic data from a Phase
I study indicate that a single ten-minute application of SoloVir(TM) ETS
delivered more than 100 times the published peak tissue levels (2 ug/ml) of
acyclovir achieved with a 1 gram dose of Valtrex(R), a leading
oral-antiviral drug marketed for the treatment of herpes labialis. In
addition, the peak tissue levels are achieved at the time of administration
|SOURCE Transport Pharmaceuticals|
Copyright©2007 PR Newswire.
All rights reserved